Harpoon Finds A Blood Cancer Partner In AbbVie

 
• By Jessica Merrill
  
SC1911_Handshake_234197374_1200.jpg
Harpoon signed an option license with AbbVie for a BCMA-targeting drug headed to the clinic
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business